Cited by 1,524Viral-associated cancers and disordersTransplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Open access

Engels, Eric A., Pfeiffer, Ruth M., Fraumeni, Joseph F., Kasiske, Bertram L., Israni, Ajay K., Snyder, Jon J., Wolfe, Robert A., Goodrich, Nathan P., Bayakly, A. Rana, Clarke, Christina A., Copeland, Glenn, Finch, Jack L., Fleissner, Mary Lou, Goodman, Marc T., Kahn, Amy, Koch, Lori, Lynch, Charles F., Madeleine, Margaret M., Pawlish, Karen, Rao, Chandrika, Williams, Melanie A., Castenson, David, Curry, Michael, Parsons, Ruth, Fant, Gregory, Lin, Monica·2011·JAMA

DOI 10.1001/jama.2011.1592PMC PMC3310893

Open this paper in CoChat — free account

Abstract

CONTEXT: Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. OBJECTIVE: To describe the overall pattern of cancer following solid organ transplantation. DESIGN, SETTING, AND PARTICIPANTS: Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. MAIN OUTCOME MEASURES: Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. RESULTS: The registry linkages yielded data on 175,732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10,656 cases and an incidence of 1375 per 100,000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100,000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n = 1504; incidence: 194.0 per 100,000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100,000 person-years) and cancers of the lung (n = 1344; incidence: 173.4 per 100,000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100,000 person-years), liver (n = 930; incidence: 120.0 per 100,000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100,000 person-years), and kidney (n = 752; incidence: 97.0 per 100,000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100,000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). CONCLUSION: Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2011.1592

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test
Erdogan, D., Heijnen, B. H. M., Bennink, R. J., Kok, M., Dinant, S., Straatsburg, I. H., Gouma, D. J., & van Gulik, T. M. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00901.x · Cited by 11,656
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S. A., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,173
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,321
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Overdiagnosis in Cancer
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,627
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312

Show all 43 references

Sorted by citations

Items 301–400 of 1,000

Solid tumors following kidney transplantation in children
Smith, J. M., Martz, K. L., McDonald, R. A., & Harmon, W. (2013) · Pediatric Transplantation · doi:10.1111/petr.12166 · Cited by 34
Cancer After Heart Transplantation: A 25-year Single-center Perspective
Keer, J. M. V., Droogné, W., Cleemput, J. V., Vörös, G., Rega, F., Meyns, B. P., Janssens, S. P., & Vanhaecke, J. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.03.037 · Cited by 34
Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation.
Bhatt, B. D., Lukose, T., Siegel, A. B., Brown, R. S., & Verna, E. C. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.050 · Cited by 33
Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues
Bedoya, J. U. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.10994 · Cited by 33
Transmissible Cancer: The Evolution of Interindividual Metastasis
Újvári, B., Gatenby, R. A., & Frédéric Thomas, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00012-0 · Cited by 35
Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers
Zamoiski, R. D., Yanik, E. L., Gibson, T. M., Cahoon, E. K., Madeleine, M. M., Lynch, C. F., Gustafson, S. K., Goodman, M. T., Skeans, M. A., Israni, A. K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3291 · Cited by 33
Self-citation
A Comparison of Immunosuppression Regimens in Hand, Face, and Kidney Transplantation
Rifkin, W. J., Manjunath, A. K., Kantar, R. S., Jacoby, A. M., Kimberly, L. L., Gelb, B. E., Diaz-Siso, J. R., & Rodriguez, E. D. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.08.006 · Cited by 33
Primary Care of the Solid Organ Transplant Recipient
Wong, C. J., & Pagalilauan, G. L. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.05.002 · Cited by 33
Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis
Liu, Q., Yan, L., Xu, C. Y., Gu, A., Zhao, P., & Jiang, Z. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-776 · Cited by 33
Cancer Risk After ABO-Incompatible Living-Donor Kidney Transplantation
Hall, E. C., Engels, E. A., Montgomery, R. A., & Segev, D. L. (2013) · Transplantation · doi:10.1097/tp.0b013e318299dc0e · Cited by 33
Self-citation
Long-term immunosuppression and malignancy in thoracic transplantation: Where is the balance?
Nair, N., Góngora, E., & Mehra, M. R. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.03.002 · Cited by 33
Oral and lip cancer in solid organ transplant patients – A cohort study from a Swedish Transplant Centre
Öhman, J. N., Rexius, H., Mjörnstedt, L., Gonzalez, H., Holmberg, E. C., Dellgren, G., & Hasséus, B. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.11.007 · Cited by 33
Angiosarcoma and Dialysis-related Arteriovenous Fistulae: A Comprehensive Review
Oskrochi, Y., Razi, K., Stebbing, J., & Crane, J. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2015.08.016 · Cited by 33
The role of mammalian target of rapamycin inhibitors in the management of post‐transplant malignancy
Klintmalm, G. B., Saab, S., Hong, J. C., & Nashan, B. (2014) · Clinical Transplantation · doi:10.1111/ctr.12357 · Cited by 32
Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study
Pettenati, C., Jannot, A., Hurel, S., Verkarre, V., Kreis, H., Housset, M., Legendre, C. M., Méjean, A., & Timsit, M. (2016) · Clinical Transplantation · doi:10.1111/ctr.12773 · Cited by 32
Breast Cancer and Transplantation
Wong, G., Au, E. H. K., Badve, S. V., & Lim, W. H. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14368 · Cited by 32
National survey of de novo malignancy after solid organ transplantation in Japan
Miyazaki, T., Sato, S., Kondo, T., Kusaka, M., Gotoh, M., Saiki, Y., Ōno, M., Kokudo, N., Enosawa, S., Satoh, S., et al. (2018) · Surgery Today · doi:10.1007/s00595-018-1628-9 · Cited by 32
Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study
Sirohi, D., Vaske, C. J., Sanborn, Z., Smith, S. C., Don, M. D., Lindsey, K., Federman, S., Vankalakunti, M., Koo, J., Bose, S., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0065-z · Cited by 32
Incidence of malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea
Jeong, S., Lee, H. S., Kong, S. G., Kim, D. J., Lee, S., Park, M.-J., Song, W., Rim, J. H., & Kim, H. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-78283-5 · Cited by 32
Subsequent Primary Malignancies in Patients with Nonmelanoma Skin Cancer in England: A National Record-Linkage Study
Ong, E. L. H., Goldacre, R., Hoang, U., Sinclair, R. D., & Goldacre, M. J. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0902 · Cited by 32
Cutaneous squamous cell carcinoma of the scalp in the immunocompromised patient: review of 53 cases
Kadakia, S., Ducic, Y., Marra, D. E., Chan, D., Saman, M., Sawhney, R., & Mourad, M. W. (2016) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-016-0545-6 · Cited by 32
Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland
García-Doval, I., Descalzo, M. Á., Mason, K. J., Cohen, A. D., Ormerod, A. D., Gómez-García, F. J., Cazzaniga, S., Feldhamer, I., Ali, H., Acosta, E. H., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16715 · Cited by 32
Risk of virus and non‐virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014
Taborelli, M., Piselli, P., Ettorre, G. M., Lauro, A., Galatioto, L., Baccarani, U., Rendina, M. G., Shalaby, S., Petrara, M. R., Nudo, F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31552 · Cited by 32
Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy
Finn, L. E., Sproat, L., Heckman, M. G., Jiang, L., Diehl, N. N., Ketterling, R. P., Tibes, R., Valdez, R., & Foran, J. M. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.09.003 · Cited by 31
Anal cancer and intraepithelial neoplasia: epidemiology, screening and prevention of a sexually transmitted disease
Medford, R. J., & Salit, I. E. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.140476 · Cited by 32
Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study
Hollyer, I., Varias, F., Ho, B., & Ison, M. G. (2019) · Transplant Infectious Disease · doi:10.1111/tid.13063 · Cited by 31
Post‐transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group
O'Neill, J. P., Sexton, D. J., O’Leary, E., O’Kelly, P., Murray, S. L., Deady, S., Daly, F., Williams, Y., Dean, B., Fitzgerald, C. W. R., et al. (2019) · Clinical Transplantation · doi:10.1111/ctr.13669 · Cited by 31
Prostate cancer in kidney transplant recipients – a nationwide register study
Ola Bratt, A., Drevin, L., Prütz, K., Carlsson, S., Wennberg, L. M., & Stattin, P. E. (2020) · British Journal of Urology · doi:10.1111/bju.15002 · Cited by 31
Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
Fialová, A., Koucký, V., Hajdůšková, M., Hladíková, K., & Špíšek, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01701 · Cited by 31
Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice
Zhao, J., Jung, S., Li, X., Li, L., Kasinath, V., Zhang, H., Naini, S. M., Mardini, A., Sabiu, G., Hwang, Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159672 · Cited by 32
Utility of Prostate Cancer Screening in Kidney Transplant Candidates
Vitiello, G. A., Sayed, B. A., Wardenburg, M. J., Perez, S. D., Keith, C. G., Canter, D. J., Ogan, K., Pearson, T. C., & Turgeon, N. A. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121182 · Cited by 31
Human Immunodeficiency Virus (HIV)– and Non-HIV–Associated Immunosuppression and Risk of Cervical Neoplasia
Silverberg, M. J., Leyden, W. A., Chi, A., Gregorich, S. E., Huchko, M. J., Kulasingam, S., Kuppermann, M., Seto, A., Smith‐McCune, K., & Sawaya, G. F. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002371 · Cited by 31
Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation – a retrospective study
Smedman, T. M., Guren, T. K., Line, P., & Dueland, S. (2019) · Transplant International · doi:10.1111/tri.13471 · Cited by 31
Immunosuppression after renal transplantation
Neuwirt, H., Rudnicki, M., Schratzberger, P., Pirklbauer, M., Kronbichler, A., & Mayer, G. J. (2019) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-019-0507-4 · Cited by 31
Heart transplantation in Japan: a critical appraisal for the results and future prospects
Kitamura, S. (2012) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-012-0110-7 · Cited by 30
High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study
Na, R., Laaksonen, M. A., Grulich, A. E., Meagher, N. S., McCaughan, G. W., KEOGH, A. M., & Vajdic, C. M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.044 · Cited by 31
Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression
Wang, Y.-J., Chi, N., Chou, N., Huang, S.-C., Wang, C., Wu, I., Yu, H., Chen, Y., Tsao, C.-I., Shun, C., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.12.071 · Cited by 30
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival
Herr, M. M., Schonfeld, S. J., Dores, G. M., Withrow, D. R., Tucker, M. A., Curtis, R. E., & Morton, L. M. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy052 · Cited by 30
Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017
Sargen, M. R., Cahoon, E. K., Lynch, C. F., Tucker, M. A., Goldstein, A. M., & Engels, E. A. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.3111 · Cited by 30
Self-citation
Checkpoint Inhibitors and Hepatotoxicity
Malnick, S. D. H., Abdullah, A., & Neuman, M. G. (2021) · Biomedicines · doi:10.3390/biomedicines9020101 · Cited by 31
Cancer Mortality Among Solid Organ Transplant Recipients in the United States During 1987–2018
Wang, J. H., Pfeiffer, R. M., Musgrove, D., Castenson, D., Fredrickson, M., Miller, J., Gonsalves, L., Hsieh, M., Lynch, C. F., Zeng, Y., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004694 · Cited by 30
Self-citation
Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis - an observational cohort study
Dalgaard, L., Fassel, U., Østergaard, L. J., Jespersen, B., Søgaard, O. S., & Jensen‐Fangel, S. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-137 · Cited by 30
Malignancy in the HIV-infected patients undergoing liver and kidney transplantation
Nissen, N. N., Barin, B., & Stock, P. G. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328355e0d7 · Cited by 30
Pre-transplant malignancy: An analysis of outcomes after thoracic organ transplantation
Beaty, C. A., George, T. J., Kilic, A., Conte, J. V., & Shah, A. S. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.11.003 · Cited by 30
Iatrogenic immunosuppression and risk of non‐Hodgkin lymphoma in solid organ transplantation: A population‐based cohort study in Australia
Na, R., Laaksonen, M. A., Grulich, A. E., Meagher, N. S., McCaughan, G. W., KEOGH, A. M., & Vajdic, C. M. (2016) · British Journal of Haematology · doi:10.1111/bjh.14083 · Cited by 30
Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system
Cui, X., Yan, C., Xu, Y., Li, D., Guo, M., Sun, L., & Zhu, Z. (2022) · Cancer Medicine · doi:10.1002/cam4.5394 · Cited by 29
Biologics in organ transplantation
Page, E. K., Dar, W. A., & Knechtle, S. J. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01456.x · Cited by 29
Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series
Santos, G. D., Haguinet, F., Cohet, C., Webb, D., Logie, J. W., Ferreira, G. L. C., Rosillon, D., & Shinde, V. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.016 · Cited by 29
Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis
Jia, Y., Yang, B., Wen, L.-L., Mu, W., Wang, Z., & Cheng, B. (2019) · Aging · doi:10.18632/aging.101756 · Cited by 29
Long-term Survival After Heart Transplantation: A Population-based Nested Case-Control Study
Suarez‐Pierre, A., Lui, C., Zhou, X. J., Giuliano, K. A., Etchill, E. W., Almaraz-Espinoza, A., Crawford, T. C., Fraser, C. D., Whitman, G. J. R., Choi, C. W., et al. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.05.163 · Cited by 29
Malignancies in adult kidney transplant candidates and recipients: current status
Serkies, K., Dębska-Ślizień, A. M., Kowalczyk, A., Lizakowski, S., & Małyszko, J. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac239 · Cited by 29
Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers
Gin, G. E., Pereira, J. F., Weinberg, A. D., Mehrazin, R., Lerner, S., Sfakianos, J. P., & Phillips, C. K. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.08.020 · Cited by 29
Role of Tregs in Cancer Dormancy or Recurrence
Manjili, M. H., & Butler, S. E. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1194428 · Cited by 29
Comprehensive Review on Colorectal Cancer and Transplant
Prenner, S. B., & Levitsky, J. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14340 · Cited by 29
Lung cancer in lung transplantation: incidence and outcome
Pérez-Callejo, D., Torrente, M., Parejo, C., Laporta, R., Ussetti, P., & Provencio, M. (2017) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2017-134868 · Cited by 29
Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients—A nationwide study
Benoni, H., Eloranta, S., Ekbom, A., Wilczek, H., & Smedby, K. E. E. (2019) · International Journal of Cancer · doi:10.1002/ijc.32299 · Cited by 29
Systematic review of ablative therapy for the treatment of renal allograft neoplasms
Favi, E., Raison, N. T. J., Ambrogi, F., Delbue, S., Clementi, M. C., Lamperti, L., Perego, M., Bischeri, M., & Ferraresso, M. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i17.2487 · Cited by 29
Posttransplant Malignancy
Rossi, A., & Klein, C. L. (2018) · Surgical Clinics of North America · doi:10.1016/j.suc.2018.09.004 · Cited by 29
The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans
Hofmann, J. N., Schwartz, K., Chow, W., Ruterbusch, J. J., Shuch, B. M., Karami, S., Rothman, N., Wacholder, S., Graubard, B. I., Colt, J. S., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0102-z · Cited by 28
Post-Transplant Malignancy in Liver Transplantation
Hsiao, C., Lee, P., Ho, C., Wu, Y., Ho, M., & Hu, R. (2014) · Medicine · doi:10.1097/md.0000000000000310 · Cited by 28
Review: Anal Intraepithelial Neoplasia in HIV-Infected Men Who Have Sex with Men: Is Screening and Treatment Justified?
Wasserman, P., Rubin, D. S., & Turett, G. S. (2017) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0063 · Cited by 29
Geriatric assessment of patients treated for cutaneous head and neck malignancies in a tertiary referral center: Predictors of postoperative complications
de Vries, J., Heirman, A. N., Bras, L., Plaat, B. E. C., Rácz, E., van Kester, M. S., Festen, S., de Bock, G. H., van der Laan, B. F. A. M., & Halmos, G. B. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.08.008 · Cited by 28
Cancer incidence in immunocompromised patients: a single-center cohort study
Ilham, S., Willis, C., Kim, K., Chung, K., Wood, B., Tan, M. S., Tan, C. J., Nguyen, D. T., Brixner, D. I., & Stenehjem, D. D. (2023) · BMC Cancer · doi:10.1186/s12885-022-10497-4 · Cited by 32
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients
Dominguez–Valentin, M., Navarro, A. G., Rahman, M. A., Kumar, S., Retière, C., Ulvestad, E., Kristensen, V. N., Lund‐Johansen, M., Lie, B. A., Enger, P. Ø., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1162 · Cited by 28
Ethical Issues in Pediatric Face Transplantation: Should We Perform Face Transplantation in Children?
Marchac, A. C., Kuschner, T., Paris, J. J., Picard, A., Vazquez, M. P., & Lantieri, L. A. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002387 · Cited by 28
De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study
Tsai, H., Lee, C., Kuo, C., See, L., Liu, F.-C., Chiou, M., & Yu, H. (2016) · Oncotarget · doi:10.18632/oncotarget.13124 · Cited by 28
Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation
Merchea, A., Shahjehan, F., Croome, K. P., Cochuyt, J. J., Li, Z., Colibaseanu, D., & Kasi, P. M. (2019) · Journal of Oncology · doi:10.1155/2019/5796108 · Cited by 28
Gender differences in cancer risk after kidney transplantation
Buxeda, A., Redondo‐Pachón, D., Pérez‐Sáez, M. J., Bartolomé-Solanas, Á., Mir, M., Pascual‐Dapena, A., Sans, A., Durán, X., Crespo, M., & Pascual, J. (2019) · Oncotarget · doi:10.18632/oncotarget.26859 · Cited by 28
Rising incidence and aggressive nature of cutaneous malignancies after transplantation: An update on epidemiology, risk factors, management and surveillance
Tufaro, A. P., Azoury, S. C., Crompton, J. G., Straughan, D. M., Reddy, S., Prasad, N. B., Shi, G., & Fischer, A. C. (2015) · Surgical Oncology · doi:10.1016/j.suronc.2015.09.007 · Cited by 27
Incidence, risk factors and outcome ofde novotumors in liver transplant recipients focusing on alcoholic cirrhosis
Jiménez‐Romero, C. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i7.942 · Cited by 27
De-novo malignancies after kidney transplantation: A long-term observational study
Fröhlich, F., Halleck, F., Lehner, L. J., Schrezenmeier, E. V., Naik, M. G., Schmidt, D., Khadzhynov, D., Kast, K., Budde, K., & Staeck, O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242805 · Cited by 27
Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Wang, T., Feng, M., Luo, C., Wan, X., Pan, C., Tang, J., Xue, F., Yin, M., Lu, D., Xia, Q., et al. (2021) · Cell Transplantation · doi:10.1177/0963689721996649 · Cited by 27
Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque
Ellis, G. I., Coker, K. E., Winn, D. W., Deng, M. Z., Shukla, D., Bhoj, V. G., Milone, M. C., Wang, W., Liu, C., Naji, A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100614 · Cited by 29
How are cancer and connective tissue diseases related to sarcoidosis?
Chopra, A., & Judson, M. A. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000186 · Cited by 27
Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study
Santangelo, M. L., Criscitiello, C., Renda, A., Federico, S., Curigliano, G., Dodaro, C. A., Scotti, A., Tammaro, V., Calogero, A., Riccio, E., et al. (2015) · BioMed Research International · doi:10.1155/2015/183523 · Cited by 27
NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma
von Boehmer, L., Mattle, M., Bode, P. K., Landshammer, A., Schäfer, C., Nuber, N., Ritter, G., Old, L. J., Moch, H., Schäfer, N., et al. (2013) · Europe PMC (PubMed Central) · doi:10.5167/uzh-79657 · Cited by 27
Tracking Cellular and Immune Therapies in Cancer
Kurtz, D. M., & Gambhir, S. S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-411638-2.00008-2 · Cited by 27
Rectal squamous cell carcinoma in immunosuppressed populations
Coghill, A. E., Shiels, M. S., Rycroft, R. K., Copeland, G. E., Finch, J. L., Hakenewerth, A. M., Pawlish, K. S., & Engels, E. A. (2015) · AIDS · doi:10.1097/qad.0000000000000873 · Cited by 27
Self-citation
Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review
Ruan, V., Czer, L. S. C., Awad, M. A., Kittleson, M. M., Patel, J. K., Arabía, F. A., Esmailian, F., Ramzy, D., Chung, J. S., Robertis, M. D., et al. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.11.034 · Cited by 27
Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States
D’Arcy, M. E., Rivera, D. R. R., Grothen, A., & Engels, E. A. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0887 · Cited by 27
Self-citation
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes
Mutsvunguma, L. Z., Rodríguez, E., Escalante, G. M., Muniraju, M., Williams, J. C., Warden, C., Qin, H., Wang, J., Wu, X., Barasa, A. K., et al. (2019) · Virology · doi:10.1016/j.virol.2019.07.026 · Cited by 27
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
Trager, M. H., Coley, S. M., Dube, G. K., Khan, S. A., Ingham, M. A., Samie, F. H., Geskin, L. J., McDonnell, D. E., Brouder, D., Saenger, Y. M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000908 · Cited by 27
Post-Transplant Lymphoproliferative Disorders
Dharnidharka, V. R., Ruzinova, M. B., & Marks, L. J. (2024) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2024.151503 · Cited by 26
The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation
Lichtenberg, S., Rahamimov, R., Green, H., Fox, B. D., Mor, E., Gafter, U., Chagnac, A., & Rozen‐Zvi, B. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2234-2 · Cited by 26
Pre-existing malignancies in renal transplant candidates—time to reconsider waiting times
Watschinger, B., Budde, K., Crespo, M., Heemann, U. W., Hilbrands, L. B., Maggiore, U., Mariat, C., Oberbauer, R. W., Oniscu, G. C., Peruzzi, L., et al. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz026 · Cited by 26
Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study
Lengwiler, E., Stampf, S., Zippelius, A., Salati, E., Zaman, K., Schaefer, N. G., Schardt, J., Siano, M., Hofbauer, G. F. L., & Study, T. S. T. C. (2019) · Swiss Medical Weekly · doi:10.4414/smw.2019.20078 · Cited by 26
Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
Małyszko, J., Kozłowski, L., Kozłowska, K., Małyszko, M., & Małyszko, J. S. (2017) · Oncotarget · doi:10.18632/oncotarget.18094 · Cited by 26
Vaccines in pediatric transplant recipients—Past, present, and future
Dulek, D. E., Maurice, A. D. S., & Halasa, N. (2018) · Pediatric Transplantation · doi:10.1111/petr.13282 · Cited by 26
Long‐term outcome of islet transplantation on insulin‐dependent diabetes mellitus: An observational cohort study
Nakamura, T., Fujikura, J., Anazawa, T., Ito, R., Ogura, M., Okajima, H., Üemoto, S., & Inagaki, N. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13128 · Cited by 27
The vaginal microbiome in uterine transplantation
Jones, B. P., Saso, S., L’Heveder, A., Bracewell‐Milnes, T., Thum, M., Díaz‐García, C., MacIntyre, D. A., Quiroga, I., Ghaem‐Maghami, S., Testa, G., et al. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15881 · Cited by 26
Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis
Sun, D., Cao, M., Li, H., Ren, J., Shi, J., Li, N., & Chen, W. (2020) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-020-00268-2 · Cited by 26
Infections in Transplant Patients
Pagalilauan, G. L., & Limaye, A. P. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.03.002 · Cited by 25
Viral infections in lung transplantation
Munting, A., & Manuel, O. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-24 · Cited by 27
Resolving Peto’s paradox: Modeling the potential effects of size‐related metabolic changes, and of the evolution of immune policing and cancer suppression
Nunney, L. (2020) · Evolutionary Applications · doi:10.1111/eva.12993 · Cited by 26
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term
Fuhrmann, J. D., Valkova, K., Moos, S. C. V., Wuthrich, R. P., Müller, T., & Schachtner, T. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac013 · Cited by 25
Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
Asleh, R., Alnsasra, H., Habermann, T. M., Briasoulis, Α., & Kushwaha, S. S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.787975 · Cited by 25
The Viral Origin of Human Breast Cancer: From the Mouse Mammary Tumor Virus (MMTV) to the Human Betaretrovirus (HBRV)
Bevilacqua, G. (2022) · Viruses · doi:10.3390/v14081704 · Cited by 25
Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society
Russo, T. P., Piccolo, V., Moscarella, E., Tschandl, P., Kittler, H., Paoli, J., Lallas, A., Braun, R. P., Thomas, L., Soyer, H. P., et al. (2022) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1204a182 · Cited by 25
Regulatory T Cells and Transplantation Tolerance
Hilbrands, R., Howie, D., Cobbold, S. P., & Waldmann, H. (2013) · Immunotherapy · doi:10.2217/imt.13.69 · Cited by 25
Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients
Sigel, K. M., Veluswamy, R. R., Krauskopf, K., Mehrotra, A., Mhango, G., Sigel, C., & Wisnivesky, J. P. (2015) · Transplantation · doi:10.1097/tp.0000000000000715 · Cited by 25

Authors: Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., Copeland, G., Finch, J. L., Fleissner, M. L., Goodman, M. T., Kahn, A., Koch, L., Lynch, C. F., Madeleine, M. M., Pawlish, K., Rao, C., Williams, M. A., Castenson, D., Curry, M., Parsons, R., Fant, G., & Lin, M.
Affiliations: National Institutes of Health (US)
Arbor Research Collaborative for Health (US)
Cancer Prevention Institute of California (US)
Michigan Department of Health and Human Services (US)
Connecticut Agricultural Experiment Station (US)
University of Hawaiʻi at Mānoa (US)
Illinois Department of Public Health (US)
University of Iowa (US)
Fred Hutch Cancer Center (US)
New Jersey Department of Health (US)
Texas Department of State Health Services (US)
Information Management Services (US)
United States Department of Health and Human Services (US)
Corresponding author: Engels, Eric A.
ORCID: Engels, Eric A.
Pfeiffer, Ruth M.
Kasiske, Bertram L.
Israni, Ajay K.
Snyder, Jon J.
Goodrich, Nathan P.
Clarke, Christina A.
Copeland, Glenn
Finch, Jack L.
Goodman, Marc T.
Kahn, Amy
Lynch, Charles F.
Madeleine, Margaret M.
Pawlish, Karen
Rao, Chandrika
Castenson, David
Curry, Michael
Fant, Gregory
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2011-11-02
Volume: 306
Issue: 17
Pages: 1891
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2011.1592
PMC: PMC3310893
OpenAlex: W1964106115
Cited by: 1,524
References: 43
Citations by year: 2026: 83 · 2025: 100 · 2024: 100 · 2023: 89 · 2022: 106 · 2021: 114 · 2020: 134 · 2019: 124 · 2018: 107 · 2017: 114 · 2016: 108 · 2015: 106 · 2014: 97 · 2013: 83 · 2012: 55
FWCI: 37.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01pc54405-9-0-0, n01pc35143-20-0-1, n01pc35139-25-0-11, n01pc35142-19-0-0, n01pc35137-18-0-2)
National Cancer Institute (N01PC35139, HHSN261201000034 C, HHSN261201000036C, HHSN261201000035C, N01‐PC035137, N01 PC035143, N01 PC35142, HHSN261201000037C, N01-PC-54405, HHSN261201000035I, N01-PC-35 137, N01PC-35143, N01 PC035139, HHSN261201000024C, N01 PC035142, N01 PC054405, ZIACP010150)
National Center for Chronic Disease Prevention and Health Promotion (5U58DP000824-04, 5U58DP000812-03, U58 DP000812, U58 DP000817, U58 DP000805, U58 DP000807, U58 DP000848-04, U58 DP000832, 5U58DP000817-05, U58 DP000824, U58/DP000808, #1U58DP000807-01, 5658DP 000805-04, U58 DP000848, 5U58/DP000808-03)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: solid organ transplant recipients, cancer risk, immunosuppression, non-Hodgkin lymphoma, lung cancer, Kaposi's sarcoma, anal cancer, melanoma, thyroid cancer, lip cancer, hepatitis C, cytomegalovirus, Epstein-Barr virus, post-transplant lymphoproliferative disorder
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Immune Tolerance, Infant, Male, Middle Aged, Neoplasms, Registries, Risk, United States, Cohort Studies, Incidence, Organ Transplantation, Immunocompromised Host, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks